Search

everythinglearnresearchcommunity

for

Search:↓

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Methyl prednisolone helps most patients with alopecia universalis regrow hair.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

The combined treatment of 3% minoxidil and 0.1% finasteride is more effective in improving hair loss than 3% minoxidil alone, with similar side effects.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Microneedling radiofrequency improves skin texture and tone by stimulating collagen and elastin.

Minoxidil alone is as effective as the combination but has fewer side effects.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Combining microneedling with 2% minoxidil is more effective and safe for treating female pattern hair loss than using minoxidil alone.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Simple methods using DHT levels effectively assess compliance.

The study developed a successful mouse model to study skin infections, highlighting the importance of choosing the right fungal strains.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.